Provided by Tiger Fintech (Singapore) Pte. Ltd.

ESSA Pharma

1.77
-0.0500-2.75%
Volume:155.68K
Turnover:274.59K
Market Cap:78.57M
PE:-2.52
High:1.81
Open:1.80
Low:1.72
Close:1.82
Loading ...
Mar 06, 2025

Major Issues Report

Form 8-K - Current report
Feb 11, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 11, 2025

Major Issues Report

Form 8-K - Current report
Dec 17, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Dec 17, 2024

Major Issues Report

Form 8-K - Current report
Dec 16, 2024

Major Issues Report

Form 8-K - Current report
Dec 06, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 08, 2024

Beneficial Ownership Change

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Nov 07, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 01, 2024

Major Issues Report

Form 8-K - Current report
Sep 14, 2024

Major Issues Report

Form 8-K - Current report
Sep 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 05, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 14, 2024

Major Issues Report

Form 8-K - Current report
Apr 05, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans